1. Home
  2. ELME vs ACIU Comparison

ELME vs ACIU Comparison

Compare ELME & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$2.04

Market Cap

198.2M

Sector

Real Estate

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.70

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELME
ACIU
Founded
1960
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
213.3M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
ELME
ACIU
Price
$2.04
$2.70
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$12.67
$10.00
AVG Volume (30 Days)
1.4M
205.6K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
741.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$206,360,000.00
N/A
Revenue This Year
$5.03
$635.38
Revenue Next Year
$4.31
$232.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$1.43
52 Week High
$17.68
$4.00

Technical Indicators

Market Signals
Indicator
ELME
ACIU
Relative Strength Index (RSI) 23.19 42.94
Support Level $1.98 $2.57
Resistance Level $2.26 $2.99
Average True Range (ATR) 0.05 0.21
MACD 0.08 -0.02
Stochastic Oscillator 29.63 17.05

Price Performance

Historical Comparison
ELME
ACIU

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: